Breast Cancer — Market Sizing Across Nine Countries

HEALTHCARE BUSINESS INSIGHTS

CENTRAL & EASTERN EUROPE · BREAST CANCER

How can a company quantify patient populations and treatment opportunities across different breast cancer markets?

The business challenge. How can a company quantify patient populations and treatment opportunities across different breast cancer markets?

Our approach. FMR conducted two waves of quantitative oncologist research with patient record collection and desk research. The work examined HR+/HER2- and triple-negative breast cancer, disease stages, treatment lines, mutations and patient characteristics.

How insights were applied. Country-level patient and treatment evidence enabled comparison of market opportunities and informed geographic prioritisation and commercial planning. These are research implications; subsequent commercial outcomes have not been independently verified.

N

Patient Population Sizing

N

Treatment Pattern Mapping

N

Country Opportunity Analysis